JNCE
Jounce Therapeutics Inc

2,991
Loading...
Loading...
Jounce Therapeutics is dedicated to transforming the treatment of cancer. The company is discovering and developing first-in-class cancer immunotherapies designed to harness the immune system to seek out and attack cancerous cells and tumors. Jounceâ??s proprietary product engine is driving this transformational approach, which has the potential to drive significantly more durable responses to treatment, extending and improving patientsâ?? quality of life. Founded by world leaders in immunobiology, cancer biology and clinical and translational medicine, Jounce Therapeutics was launched in 2013 with funding from leading life sciences investor, Third Rock Ventures.
Sector:
Commercial Services
Industry:
Miscellaneous Commercial Services
Employees:
N/A

Frequently Asked Questions

What is Market Cap of Jounce Therapeutics Inc?
What is the 52-week high for Jounce Therapeutics Inc?
What is the 52-week low for Jounce Therapeutics Inc?
What is Jounce Therapeutics Inc stock price today?
What was Jounce Therapeutics Inc stock price yesterday?
What is the PE ratio of Jounce Therapeutics Inc?
What is the Price-to-Book ratio of Jounce Therapeutics Inc?
What is the 50-day moving average of Jounce Therapeutics Inc?

Latest JNCE News

View
No JNCE news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.